Revenue
2017
2018
2019
2020
2021
2022
2024
2025
CorMedix Inc. (CRMD)
Price—Loading quote
Net income
2018
2019
2020
2021
2022
2023
2024
2025
Free cash flow
2018
2019
2020
2021
2022
2023
2024
2025
Total cash / debt
CashTotal debt
2018
2019
2020
2021
2022
2023
2024
2025
Financial statements
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $311.7M | $43.5M | — | $65,408 | $190,936 | $239,231 | $283,266 | $429,797 | $329,327 | $224,105 | $210,130 | $189,274 | $2,001 | $0 | — | — | — | — | — |
| Gross profit | $275.7M | $40.3M | — | $61,674 | $41,998 | $34,385 | −$89,968 | $33,011 | $214,363 | −$142,568 | −$108,588 | −$256,525 | −$199,604 | $0 | — | — | — | — | — |
| Research & development | $19.3M | $3.9M | $13.2M | $10.7M | $13.1M | $13.4M | $11.1M | $18.8M | $24.5M | $15.7M | $6.3M | $1.3M | $1.2M | $1.1M | $4.1M | $5.5M | — | — | — |
| Operating expenses | $125.6M | $62.6M | $49.0M | $30.7M | $29.5M | $27.3M | $20.9M | $26.9M | $33.1M | $24.6M | $16.5M | $8.6M | $4.7M | $3.0M | $7.2M | $8.5M | — | — | — |
| Operating income | $150.1M | −$22.4M | −$49.0M | −$30.6M | −$29.4M | −$27.2M | −$21.0M | −$26.9M | −$32.9M | −$24.8M | −$16.7M | −$8.9M | −$4.9M | −$3.0M | −$7.2M | −$8.5M | — | — | — |
| EBITDAderived | $164.7M | −$22.0M | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Net income | $163.1M | −$17.9M | −$46.3M | −$29.7M | −$28.2M | −$22.0M | −$16.4M | −$26.8M | −$33.0M | −$24.6M | −$18.2M | −$20.5M | −$9.1M | −$3.4M | −$6.7M | −$10.9M | −$8.1M | −$9.0M | −$7.2M |
| Basic EPSper diluted share | $2.25 | -$0.30 | -$0.91 | -$0.74 | -$0.75 | -$0.77 | -$1.80 | -$1.51 | -$0.60 | -$0.65 | -$0.58 | -$0.96 | -$0.69 | -$0.30 | -$0.58 | -$1.15 | — | — | — |
| Diluted EPSper diluted share | $2.04 | -$0.30 | -$0.91 | -$0.74 | -$0.75 | -$0.77 | -$1.80 | -$1.51 | -$0.60 | -$0.65 | -$0.58 | -$0.96 | -$0.69 | -$0.30 | -$0.58 | -$1.15 | — | — | — |
Insider buys & sells
| Transaction | Insider | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Jan 21, 2026Form 4 · 10b5-1 | Dillione JanetDirector | SellCommon Stock | 10.0K | $6.88 | $68.8K | 38.5K |
| Dec 30, 2025Form 4 · 10b5-1 | DUNTON ALAN WDirector | SellCommon Stock | 20.0K | $13.00 | $260.0K | 40.3K |
| Dec 18, 2025Form 4 · 10b5-1 | Todisco JosephChief Executive Officer | SellCommon Stock | 30.0K | $12.00 | $360.0K | 509.5K |
| Dec 9, 2025Form 4 · 10b5-1 | Dillione JanetDirector | SellCommon Stock | 34.0K | $12.00 | $408.0K | 48.5K |
| Dec 9, 2025Form 4 | Lefkowitz Steven WDirector | SellCommon Stock | 40.0K | $11.88 | $475.2K | 80.5K |